The AU’s disease control body said on Thursday that it is not “walking away” from AstraZeneca’s Covid-19 vaccine after trial data showed it had greatly reduced efficacy against the coronavirus variant dominant in SA.

African countries are due to receive 100-million doses of the AstraZeneca shot this year under an AU vaccine plan...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.